THE TOTALLY IMPLANTABLE MINIMALLY INVASIV E HEPATIC-ARTERY CATHETER FOR INTRAARTERIAL CHEMOTHERAPY OF UNRESECTABLE LIVER METASTASES IN CASES OF DYSFUNCTION OF ARTERIAL ACCESS DEVICES
Ct. Germer et al., THE TOTALLY IMPLANTABLE MINIMALLY INVASIV E HEPATIC-ARTERY CATHETER FOR INTRAARTERIAL CHEMOTHERAPY OF UNRESECTABLE LIVER METASTASES IN CASES OF DYSFUNCTION OF ARTERIAL ACCESS DEVICES, Chirurg, 67(4), 1996, pp. 458-462
Dysfunction of arterial access devices used in accociation with intra-
arterial chemotherapy for the treatment of unresectable liver metastas
es usually requires stopping the therapy or relaporotomy and reimplant
ation of a new arterial catheter. OUT initial experience technique, th
e so-called MIAH catheter (minimally invasive hepatic artery catheter)
in 36 patients (age 37-78 years) are reported. The MIAH catheter was
percutanously inserted into the subclavian artery under sonographic gu
idance and advanced via the descending aorta selectively into the hepa
tic artery. Finaly it was connected to a totally implantable pump. The
re were no deaths related to the operation. Operative or early complic
ations occurred in 5 cases (13.8%) late complications were seen in 13
patients (36.1%). Nevertheless continuation of intraarterial chemother
apy was possible in all cases. In cases of dysfunction of conventional
arterial access devices the MIAH catheter makes it possible to contin
ue intra-arterial chemotherapy without requiring laporotomy.